Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Karuna Therapeutics Inc
(NQ:
KRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Karuna Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Why Karuna Therapeutics Shares Are Trading Sharply Lower
December 06, 2022
Karuna Therapeutics Inc (NASDAQ: KRTX) shares are trading lower by 11.63% to $200.56 going into the close of Tuesday's session after the company announced a CEO transition. What Happened?
Via
Benzinga
Karuna Therapeutics Appoints Bill Meury as President and Chief Executive Officer
December 06, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Looking Into Karuna Therapeutics's Return On Capital Employed
November 23, 2022
Via
Benzinga
My 3 Top Biotech Stock Picks for 2023
November 22, 2022
Biotech stocks are set to shine in 2023.
Via
The Motley Fool
Biotech Stocks Embrace The Neuroscience Renaissance With Biogen, Amylyx At The Helm
November 16, 2022
Neurodegenerative disorders could mean big bucks for some biotechs.
Via
Investor's Business Daily
Karuna Therapeutics: Q3 Earnings Insights
November 03, 2022
Karuna Therapeutics (NASDAQ:KRTX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Analysts Have This to Say About Karuna Therapeutics
November 01, 2022
Within the last quarter, Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for Karuna Therapeutics
September 13, 2022
Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter:
Via
Benzinga
Karuna Therapeutics Reports Third Quarter 2022 Financial Results and Provides General Business Updates
November 03, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
What 12 Analyst Ratings Have To Say About Karuna Therapeutics
November 01, 2022
Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why
August 23, 2022
Via
Benzinga
Karuna Therapeutics to Present at the Jefferies 2022 London Healthcare Conference
November 01, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
2 On-Fire Biotech Stocks That Are Crushing the Bear Market
October 31, 2022
The biotech sector is down this year, but these two biopharmaceutical stocks have delivered strong returns.
Via
The Motley Fool
Opportunities In Large Cap Growth And Small Cap
October 20, 2022
The third quarter was true
Via
Talk Markets
Biotech Stocks Well-Positioned For The Fourth Quarter
October 12, 2022
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
Via
Talk Markets
PsychoGenics Announces Extension of Ongoing Drug Discovery Collaboration with Karuna Therapeutics
October 11, 2022
From
PsychoGenics Inc.
Via
Business Wire
Karuna Therapeutics to Present Data from the Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia at the 35th European College of Neuropsychopharmacology (ECNP) Congress
October 06, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Where Karuna Therapeutics Stands With Analysts
September 29, 2022
Over the past 3 months, 12 analysts have published their opinion on Karuna Therapeutics (NASDAQ:KRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Mainz Biomed (MYNZ) nominates two notable leaders in key areas of the diagnostics field to its Board of Directors
September 29, 2022
Via
AB Newswire
7 Momentum Stocks to Buy Now for Extraordinary Gains
September 26, 2022
Momentum stocks aren't as risky as some say, and these winning stocks are strong examples for investors to consider.
Via
InvestorPlace
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022
September 20, 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.
Via
Talk Markets
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Via
Investor's Business Daily
Where Karuna Therapeutics Stands With Analysts
September 13, 2022
Over the past 3 months, 12 analysts have published their opinion on Karuna Therapeutics (NASDAQ:KRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
What 12 Analyst Ratings Have To Say About Karuna Therapeutics
September 13, 2022
Within the last quarter, Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings:
Via
Benzinga
Karuna Therapeutics to Present at Upcoming Investor Conferences
September 01, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
August 29, 2022
These names are benefitting from M&A, clinical data and promising regulatory actions.
Via
Investor's Business Daily
This Analyst Raises PT On Karuna Therapeutics By 100%; Wells Fargo Predicts $2,300 For This Stock
August 15, 2022
Piper Sandler boosted the price target on First Solar, Inc. (NASDAQ: FSLR) from $120 to $165. Piper Sandler analyst Kashy Harrison maintained an Overweight rating on the stock. First Solar shares rose...
Via
Benzinga
Karuna Therapeutics Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
August 12, 2022
From
Karuna Therapeutics, Inc.
Via
Business Wire
Coinbase, Trade Desk, H&R Block And Some Other Big Gainers From Wednesday
August 11, 2022
U.S. stocks closed higher on Wednesday following the release of inflation data. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.